31 results on '"Bertetto, O"'
Search Results
2. B13 - Start (active surveillance or radical treatment for newly diagnosed patients with a localized, low risk, prostate cancer): an epidemiological study of the Oncology Network of Piemonte and Valle d’Aosta. Update 2017
3. Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey
4. Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer
5. Quality of life studies and genito-urinary tumors
6. SC46 - Cancer specific anxiety and depression levels in localized low-risk prostate cancer who choose active surveillance or radical treatment: Findings from the START study
7. PHS151 - A Pilot Study About The Appropriateness Of The Breast Cancer Care Pathway In A Local Health Authority ASL CN2 (Piedmont, ALBA BRA-Italy) based on E.Pic.A. (Economic Appropriateness Of An Integrated Care Pathway) Protocol
8. T14 - The continuing training program of oncology network of Piemonte and Valle d'Aosta: a model for improving the management of oncologic patients
9. T10 - Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): a negligible risk?
10. S7 - Medication-Related Osteonecrosis of JAW (MR-ONJ) After Bisphosphonates, Denosumab and other Drugs in Advanced Cancer Patients: Recent Experience Data from Rete Oncologica Piemonte – Valle D’aosta (North-Western Italy Cancer Network)
11. P7 - The follow-up and lifestyle (FUCSAM project). Oncology Network of Piemonte and Valle d'Aosta: update 2017
12. D28 - Pancreatic cancer: sharing a nutrition education project with the patients and their care givers
13. P085 - Feasibility of a low cost life-style intervention programme for breast cancer patients by volunteer health support
14. S24 - The follow-up and lifestyle (FUCSAM project). Oncology Network of Piemonte and Valle d'Aosta (ROPVdA): update 2016.
15. H04* - Chemotherapy extravasation: a survey within the Oncology Network of Piedmont and Valle d'Aosta
16. E06 - Activation of Palliative Cares by hospital oncologists: first results of a survey conducted by Rete Oncologica del Piemonte e della Valle d'Aosta
17. C12 - START (Active Surveillance or Radical Treatment for newly diagnosed patients with a localized, low risk, prostate cancer): an epidemiological study of the Oncology Network of Piemonte and Valle d'Aosta
18. 3088 Increase and decrease of jaw osteonecrosis (ONJ) in patients treated with intravenous bisphosphonates (BP): impact of preventive measures and reduced prescriptions in the experience of the “Rete Oncologica di Piemonte e Valle d'Aosta” ONJ study group
19. 1131 POSTER Osteonecrosis of the jaw (ONJ) in patients treated with Bisphosphonates (BP): the experience of the "Rete Oncologica di Piemonte e Valle D'Aosta" (North-Western Italy)
20. Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
21. P-542 Carboplatin (C) and docetaxel (D) in the second-line treatment of non-small cell lung cancer (NSCLC) patients pretreated with platinum-based regimens. A Phase II trial
22. Merkel's cell carcinoma: our experience
23. Changes in circulating dendritic cells in metastatic or locally advanced pancreatic carcinoma patients during chemotherapy
24. Survival in the surgery of pancreatic tumours with vascular involvement
25. Vinorelbine for recurrent adenocarcinoma-like salivary gland malignancies
26. 715 Fluorouracil (5-FU) and levo-folinic acid (LFA) in elderly patients with advanced colorectal cancer: Active and safe combination?
27. Goserelin versus goserelin plus mitomycin C in advanced (stabe D) previously untreated prostatic cancer. A randomized study
28. Adriamycin and ifosfamide combination regimen in the treatment of advanced soft tissues sarcomas
29. Carboplatin and fluorouracil in cervix tumors
30. Granulocyte colony stimulating factor (G-CSF) activity in prevention of infections in neutropenic patients
31. LHRH agonist ICI 118.630 (Zoladex depot) (Z) versus Z plus Cyproterone Acetate (CPA) in advanced prostatic cancer. Preliminary report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.